THC Therapeutics, Inc. (THCT)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jul 9, 2026
THC Therapeutics Statistics
Total Valuation
THCT has a market cap or net worth of 20,133. The enterprise value is 897,823.
| Market Cap | 20,133 |
| Enterprise Value | 897,823 |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
THCT has 40.27 million shares outstanding.
| Current Share Class | 40.27M |
| Shares Outstanding | 40.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +16.64% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -2,866.01% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 14.26% |
| Weighted Average Cost of Capital (WACC) | 34.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -811,562 |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +150.00% in the last 52 weeks. The beta is 173.97, so THCT's price volatility has been higher than the market average.
| Beta (5Y) | 173.97 |
| 52-Week Price Change | +150.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 47.31 |
| Average Volume (20 Days) | 9,114 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -541,975 |
| Pretax Income | -811,562 |
| Net Income | -811,562 |
| EBITDA | -540,578 |
| EBIT | -541,975 |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
The company has 35 in cash and 876,895 in debt, with a net cash position of -876,860 or -0.02 per share.
| Cash & Cash Equivalents | 35 |
| Total Debt | 876,895 |
| Net Cash | -876,860 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -3.80M |
| Book Value Per Share | -0.09 |
| Working Capital | -3.81M |
Cash Flow
| Operating Cash Flow | -183,273 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1,397 |
| Net Borrowing | 85,458 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
THCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.76% |
| Shareholder Yield | -8.76% |
| Earnings Yield | -4,031.00% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 10, 2018. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 10, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |